News
nRichDX Launches Two New Products for Liquid Biopsy Applications
The Revolution Circulating Free Total Nucleic Acid (cfTNA) Kit™ and cfDNA Reference Standard products are designed to advance liquid biopsy application development....
nRichDX and Eppendorf to Jointly Present at ESHG 2022 Meeting
IRVINE, California, April 14, 2022 – nRichDX and Eppendorf will present data from the Revolution Semi-Automated Workflow™ powered by the epMotion® 5073 instrument at the upcoming European Society for Human Genetics (ESHG) 2022 Conference in Vienna, Austria on Saturday, June 11, 2022, from 10:00 am – 11:30 am CET....
nRichDX Launches Revolution Sample Prep™ Service
New cfDNA and ctDNA extraction service for researcher-provided blood and urine samples with TAT of one week or less....
nRichDX Introduces In Kind Grants for Academic Researchers
Grant program for qualified and approved cfDNA Researchers in academia and non-profit organizations for the purpose of advancing their research projects by providing more cfDNA and ctDNA than is available using current methods. IRVINE, Calif., Jun 8, 2021– nRichDX® Inc. announces the Revolution™ Sample Prep Grant Program which provides grants of Processor hardware and Revolution kits to researchers extracting circulating free DNA and circulating tumor DNA in their work. The Revolution Sample Prep System enables the extraction of more cfDNA and ctDNA from samples of blood or urine. The System extracts from 1 mL - 20 mL in a single extraction and unlike other methods, does not require cfDNA yield-lowering sample pooling, concentration, or transfer steps....